Nasal Spray Esketamine

Pharmaceutical Grade Esketamine Nasal Spray (56mg) Spravato

This category focuses on high-precision Esketamine nasal spray formulations, specifically calibrated to 56mg concentrations for clinical research and therapeutic evaluation. Utilizing the S(+) enantiomer (CAS 33643-46-8), these intranasal solutions are prepared to USP Grade standards, providing a professional-grade alternative for studies requiring specific dosage benchmarks established in clinical protocols.

Technical Specifications & Research Parameters

• Chemical Identity: Esketamine Hydrochloride (S-Ketamine)
• Dosage Concentration: 56mg per administration unit, optimized for consistent bioavailability.
• Formulation Standards: Sterile, aqueous S-enantiomer solution verified through rigorous HPLC analytical protocols.

By offering 56mg Esketamine formulations, we support institutional research into NMDA receptor antagonism and advanced neuro-therapeutic synthesis. Our commitment to data transparency and risk mitigation ensures that each unit provides the precise chemical indexing and clinical safety signals required for institutional documentation.

All 56mg intranasal preparations are handled under strict pharmaceutical quality control. We maintain a focus on the Mechanism of Action and the Science of Synthesis, ensuring our products meet the regulatory compliance and purity benchmarks demanded by the global scientific community.